可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] CIBIS-II Investigators and committees the. cardiac insufficiency bisoprolol study II (CIBIS-II ) : a randomized trial [J]. Lancet,1999, 353: 9- 13.
[2] MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF ) [J].Lancet, 1999, 353: 2001.
[3] Krum H,Whorlow S. Meta-Analysis of effect of beta-blocker therapy on mortality on NYHA class IV CHF patients [J].Circulation (Sepplement1) ,1999, 100 (18) : I- 208.
[4] Packer M. COPERNICUS (Carvedilol prospective randomiged cumulative survival) : Evaluates the effects of carvedilol top-of ACE on major cardiac events in patients with heart failure NYHA II ~ IV XXII congress of the europeau society of cardillgy[C], 2000. Aug26~ 30. Hot-line symposium.
[5] Zannad F, Perez A, Pitt B, et al. Mechanisms contributing to the survival benefit with aldosterone antagonist therapy in heart failure. Effects on neurohormones and cardiac fibrosis: a substudy of RALES [J]. Eur Heart J , 2000, 21 (Abstract Supplement) : 22.
[6] Guazzi M, Pontone G,Agostonip P, et al. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure[J].Am J of Cardiol,1999, 84 (9) : 1038- 1043.
[7] Milfred-LaForest SK, Shubert J ,Mendoza B, et al. Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and oral angiotensin-converting enzyme inhibitors[J]. Am J Cardiol, 1999, 84: 894-899.
[8] O’Connor CM , Gattis WA , Uretshy BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the flolan international randomized survival trial (FIRST ) [J]. Am Heart J , 1999, 138 (1) : 78- 85.
[9] Kukin ML , Frendenberger RS,Mannino MM , et al. Short-term and long-term hemnondynamic and clinical effects of metroprolol alone and combined with amlodipine in patients with chronic heart failure[J]. Am Heart J , 1999, 138, 261- 268.
[10] Consin J , Diez J , Effects of type of diuretic on mortality in patients with chronic congestive heart failure. European Heart J , 2000, 21 (Abstract Supplement) : 296.
[11]Yip GWK, Ho PPY,Woo KS. Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in hongkong[J]. Am J Cardiol, 1999, 84: 563- 567.
[12] Starling RC, Mccarthy PM , Hoercher KJ , et al. Partial left ventriculectomy for dilated cardiomyopathy: Aviable option for end stage heart failure? [J] Circulation (Supplement1) , 1999, 100(18) : I- 801.
[13]Etienna Y, Valls-Bertault V , Touiza A , et al. Does permenent left ventricular-based pacing decrease mitral regurgitation in
patients with severe congestive heart failure? [J] European Heart J , 2000, 21 (Abstract supplement) : 410.
[14] Walker S, Levy T, Rex S, et al. Perceived benefits of biventricular pacing are not supported by objective failure [J].Eur Heart J , 2000, 21 (Abstract Supplement) : 190.
[15]Florea V , Henin M , Cicoira M , et al. Survival in the elderly with chronic heart faiulre, role of diastolic dysfunction [J]. Eur Heart J , 2000, 21 (Abstract Supplement) : 216.
[16] Bergmeier C, Kilkowski A , Kleemann T, et al. Left ventricular dysfunction in clinical practice: Relative mitral valve regurgitation as strong indenpent predictor of long-term mortlaity [J]. Eur Heart J , 2000, 21 (Abstract Supplement ) :536.